114 articles in this category. All content is educational and for research purposes only.
5-Amino-1MQ research profile: how NNMT inhibition works, what the mouse studies show, why no human data exist, and platform pricing across 62 suppliers.
Abarelix (Plenaxis) was the first GnRH receptor antagonist approved by the FDA, establishing the pharmacological foundation for modern androgen deprivation…
AMG133 (MariTide) is a bispecific antibody-peptide conjugate combining GIPR antagonism with GLP-1 agonism, achieving ~20% average weight loss at 52 weeks with once-monthly dosing in Phase 2 trials.